Agenix
- Short interest
- 0.00%
- as of 14 July 2016
- Reported shorts
- 90
- Shares on issue
- 157.276M
Agenix (AGX) Short Interest
Agenix (ASX:AGX) had 0.00% of shares reported as short positions as of 14 July 2016, representing 90 shares. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Agenix
Agenix is a biotechnology company focused on developing innovative pharmaceuticals for unmet medical needs. The company leverages cutting-edge technology to create unique therapeutic solutions, aiming to improve patient outcomes and establish a strong presence in the healthcare market.
Company profile →Agenix (ASX:AGX) has 0.00% of its shares on issue reported as short positions as of 14 July 2016, or about 90 shares. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Latest AGX news
All news- Derivatives Disclosure - September 2026
asx · 6 Oct 2026
- Units on Issue & Movements - September 2026
asx · 6 Oct 2026
- Annual Report
asx · 21 Sept 2026
Be the first to discuss AGX
Start a research thread or post the first pulse update